SECAUCUS, N.J., Jan. 19, 2018 /PRNewswire/ -- Quest Diagnostics
(NYSE: DGX), the world's leading provider of diagnostic
information services, today announced that it has been named one of
the "World's Most Admired Companies" for 2018 by Fortune for the
third consecutive year.
The annual survey designated Quest Diagnostics as one of only
five companies in the "Health Care: Pharmacy and Other Services"
industry to attain Most Admired status. The company advanced
one spot in the industry ranking from last year.
"We are honored to be included for the third consecutive year,"
said Steve Rusckowski, Chairman, President and CEO. "This
is a tribute to our 45,000 employees who are committed to
excellence in everything they do, enabling us to promote a
healthier world, build value, and create an inspiring
workplace."
Fortune's "World's Most Admired Companies" list is based on
surveys of 680 companies from 29 countries, asking executives,
directors, and analysts to rate enterprises in their own industry
on nine criteria, from investment value and quality of management
and products to social responsibility and ability to attract
talent.
About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve
health outcomes. Derived from the world's largest database of
clinical lab results, our diagnostic insights reveal new avenues to
identify and treat disease, inspire healthy behaviors and improve
health care management. Quest annually serves one in three
adult Americans and half the physicians and hospitals
in the United States, and our 45,000 employees understand
that, in the right hands and with the right context, our diagnostic
insights can inspire actions that transform
lives. www.QuestDiagnostics.com.
View original content with
multimedia:http://www.prnewswire.com/news-releases/quest-diagnostics-named-one-of-2018-worlds-most-admired-companies-by-fortune-magazine-for-third-consecutive-year-300585255.html
SOURCE Quest Diagnostics